Childhood Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Childhood Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
A Mayo Clinic-sponsored clinical trial is evaluating how long calaspargase pegol maintains active asparaginase levels in pediatric patients.…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home [NA]
A clinical trial evaluating programs to help children with acute lymphoblastic leukemia maintain home-based maintenance medication has been …
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia [Phase 2]
This Phase 2 trial examines hematopoietic stem cell transplantation for infant leukemia and has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities [Phase 3]
Phase 3 trial update on innovative tools for vector-borne disease control in conflict-affected communities; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating sorafenib in pediatric patients with relapsed or refractory solid tumors or leukemia; results completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
Phase 1/2 trial updates for AUTO3 (CD19/22 CAR T cells) in B-cell acute lymphoblastic leukemia, including recurrent/refractory pediatric cas…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant [Phase 3]
Phase 3 trial updating chlorhexidine gluconate cleansing for preventing central line-associated bloodstream infections and MDR organism acqu…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial update on combination chemotherapy for newly diagnosed acute lymphoblastic leukemia in young patients, with completed status a…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 2]
Phase 2 clinical trial update evaluating alisertib in pediatric patients with various recurrent or refractory solid tumors and leukemia; stu…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the use of nilotinib and imatinib after donor stem cell transplant in patients with acute ly…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 trial updated on dosing of vincristine (low-dose vs high-dose) plus combination chemotherapy for relapsed B-cell acute lymphoblast…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases [Phase 3]
Phase 3 trial evaluating donor bone marrow transplant with or without G-CSF in young patients with hematologic cancers or related diseases; …
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [Phase 1]
Phase 1 clinical trial update evaluating peg-aspargase with combination chemotherapy in younger patients with newly diagnosed high-risk acut…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
This completed clinical trial from the Children's Oncology Group studied biomarkers as a diagnostic tool in samples from younger patients wi…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
A completed clinical trial evaluating Lestaurtinib with or without chemotherapy in young patients with childhood leukemia.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
Completed clinical trial update studying gene analyses in samples from younger patients with relapsed childhood acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: 506U78 in Treating Patients With Refractory Hematologic Cancer [Phase 2]
This entry notes the completion of a Phase 2 trial of 506U78 in relapsed pediatric hematologic cancers, including recurrent childhood acute …